Efgartigimod alfa Uses, Dosage, Side Effects and more
Efgartigimod alfa is under investigation in clinical trial NCT03669588 (An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness).
| Trade Name | Efgartigimod alfa |
| Generic | Efgartigimod alfa |
| Efgartigimod alfa Other Names | Efgartigimod alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
